According to one study that compared PIVKA-II and AFP values among HBV-related HCC, PIVKA-II is the better marker, and their combination may improve early HCC detection (Ng & Wu, 2012; Chon et al., 2012). This evidence concerns the gene AFP and hepatocellular carcinoma.